Snoring affects the quality of life of hundreds of millions of people and can lead to obstructive sleep apnea (OSA ... In one study, 27 people with snoring or mild OSA used the device for ...
The sleep disorder also appears to have direct effects on brain health, a new study shows. People with sleep apnea appear to experience ... compared to 28% who had mild sleep problems and 16% ...
It's currently in phase three trials, but according to phase two results, AD109 offers meaningful improvements to sleep apnea ...
Learn More: What Causes Mild Obstructive Sleep ... gasping for air during sleep, and daytime fatigue are highly suggestive of ...
Sleep apnea disrupts breathing during sleep. This can lead to Type 2 diabetes. Millions suffer from sleep apnea. The link between these conditions is often overlooked. Sleep studies diagnose sleep ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
A common sleep disorder ... approved to treat OSA. The FDA’s decision was informed by data from the SURMOUNT-OSA Phase III trials (NCT05412004). These studies evaluated Zepbound’s ...
Friday's FDA approval of Zepbound for treating moderate to severe sleep apnea came after the SURMOUNT-OSA phase 3 clinical trials -- two randomized, double-blind, placebo-controlled studies of 469 ...